|
RS Crores
|
| |
FY00 |
FY01* |
FY02** |
FY03 |
FY04*** |
FY05 |
FY06# |
FY07^ |
FY08 |
FY09 |
| Operating Results: |
|
Sales
|
982 |
1100 |
1200 |
1285 |
1236 |
1417 |
1757 |
2080 |
2396 |
2834 |
|
Other Income
|
34 |
19 |
12 |
7 |
9 |
9 |
13 |
26 |
34 |
47 |
|
EBITDA
|
128 |
137 |
144 |
162 |
164 |
217 |
300 |
376 |
443 |
517.3 |
|
EBITDA Margins (%)
|
13.0 |
12.5 |
12.0 |
12.6 |
13.3 |
15.3 |
17.1 |
18.1 |
18.5 |
18.3 |
|
Profit Before Tax (PBT)
|
81 |
85 |
82 |
106 |
124 |
176 |
257 |
319 |
384 |
445 |
|
Taxes
|
4 |
7 |
14 |
14 |
15 |
19 |
30 |
39 |
52 |
54 |
|
Tax Rate (%)
|
4.5 |
8.5 |
16.6 |
13.3 |
12.0 |
10.8 |
11.7 |
12.1 |
13.4 |
12.1 |
|
Profit After Tax (PAT)
|
77 |
78 |
64 |
85 |
107 |
156 |
214 |
282 |
333 |
391 |
|
PAT Margins (%)
|
7.9 |
7.1 |
5.4 |
6.6 |
8.6 |
11.0 |
12.2 |
13.5 |
13.9 |
13.8 |
| Financial Position: |
|
Fixed Assets (Net)
|
251 |
243 |
371 |
257 |
250 |
295 |
512 |
379 |
465 |
559 |
|
Current Assets, Loans & Advances
|
412 |
393 |
504 |
522 |
340 |
408 |
471 |
640 |
774 |
951 |
|
Current Liabilities & Provisions
|
108 |
158 |
183 |
241 |
294 |
400 |
436 |
452 |
732 |
808 |
| Net Working Capital |
304 |
235 |
322 |
281 |
46 |
8 |
35 |
189 |
42 |
143 |
| Days of Sales |
113 |
78 |
98 |
80 |
14 |
2 |
7 |
33 |
6 |
18 |
|
Total Assets
|
609 |
558 |
705 |
640 |
433 |
543 |
624 |
670 |
749 |
1081 |
|
Share Capital
|
29 |
29 |
29 |
29 |
29 |
29 |
57 |
86 |
86 |
86.5 |
|
Reserves & Surplus
|
292 |
334 |
365 |
388 |
257 |
335 |
440 |
393 |
531 |
731 |
|
Shareholders Funds
|
320 |
362 |
393 |
417 |
286 |
364 |
497 |
480 |
618 |
818 |
|
Loan Funds
|
289 |
196 |
304 |
964 |
132 |
164 |
121 |
160 |
99 |
228 |
|
Total Capital Employed
|
609 |
558 |
705 |
640 |
433 |
543 |
624 |
670 |
749 |
1081 |
| Return Ratios: |
| ROCE (%) |
17.0 |
19.5 |
12.6 |
16.1 |
28.6 |
31.3 |
39.0 |
45.7 |
47.6 |
38.8 |
| RONW (%) |
24.7 |
22.0 |
16.6 |
20.6 |
38.1 |
43.5 |
46.1 |
61.3 |
55.3 |
48.4 |
| Equity Share Data: |
| Earnings Per Share (Rs) |
27.1 |
2.7 |
2.3 |
3.0 |
3.7 |
5.4 |
3.7 |
3.3 |
3.9 |
4.5 |
| Dividend Per Share (Rs) |
10.0 |
1.0 |
0.5 |
1.4 |
2.0 |
2.5 |
1.8 |
1.42 |
1.5 |
1.75 |
| No of Shares (In Crs) |
2.9 |
2.9 |
28.6 |
28.6 |
28.6 |
28.6 |
57.3 |
86.3 |
86.4 |
86.5 |
Sales are Gross Sales i.e Net off Sales tax/VAT paid
* Stock split from Rs 10/share to Rs 1/ share
** Consolidated results from FY02 onwards
*** Dabur Pharma got de-merged.
# Bonus issue of 1:1 was issued during the year
^ Bonus Issue of 1:2 was issue during the year